SEC Form 4 · accession 0001144204-16-137742
Synthetic Biologics, Inc. · SYN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Scott Riley
Officer — Chief Executive Officer · Director
Period of report
Nov 30, 2016
Accepted (ET)
Dec 2, 2016 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000894158
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $0.80 | Nov 30, 2016 | A | 1,129,000 | A | Nov 30, 2016 | Nov 29, 2023 | Common Stock | 1,129,000 | 1,129,000 | D |
Explanation of responses
- F1These options will vest monthly on a pro rata basis over 36 consecutive months.